These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34985768)

  • 41. [The role of human fibroblast growth factor receptor 1-IIIb isoform in proliferation of pancreatic ductal cells and its effects to mitogen-activated protein kinase].
    Liu ZB; Yang YM; Qiao QL; Wan YL; Kornmann M; Huang YT
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2812-6. PubMed ID: 17200012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TUG1 promotes the development of prostate cancer by regulating RLIM.
    Guo BH; Zhao Q; Li HY
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1926-1933. PubMed ID: 30915735
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibroblast growth factor receptor 1-transformed mammary epithelial cells are dependent on RSK activity for growth and survival.
    Xian W; Pappas L; Pandya D; Selfors LM; Derksen PW; de Bruin M; Gray NS; Jonkers J; Rosen JM; Brugge JS
    Cancer Res; 2009 Mar; 69(6):2244-51. PubMed ID: 19258500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyperactivated FRS2α-mediated signaling in prostate cancer cells promotes tumor angiogenesis and predicts poor clinical outcome of patients.
    Liu J; You P; Chen G; Fu X; Zeng X; Wang C; Huang Y; An L; Wan X; Navone N; Wu CL; McKeehan WL; Zhang Z; Zhong W; Wang F
    Oncogene; 2016 Apr; 35(14):1750-9. PubMed ID: 26096936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FGF1-FGFR1 axis promotes tongue squamous cell carcinoma (TSCC) metastasis through epithelial-mesenchymal transition (EMT).
    Jiao J; Zhao X; Liang Y; Tang D; Pan C
    Biochem Biophys Res Commun; 2015 Oct; 466(3):327-32. PubMed ID: 26362179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells.
    Takase N; Koma Y; Urakawa N; Nishio M; Arai N; Akiyama H; Shigeoka M; Kakeji Y; Yokozaki H
    Cancer Lett; 2016 Sep; 380(1):47-58. PubMed ID: 27317650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Catalytically inactive receptor tyrosine kinase PTK7 activates FGFR1 independent of FGF.
    Shin WS; Lee HW; Lee ST
    FASEB J; 2019 Nov; 33(11):12960-12971. PubMed ID: 31490704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FGFR1 signaling stimulates proliferation of human mesenchymal stem cells by inhibiting the cyclin-dependent kinase inhibitors p21(Waf1) and p27(Kip1).
    Dombrowski C; Helledie T; Ling L; Grünert M; Canning CA; Jones CM; Hui JH; Nurcombe V; van Wijnen AJ; Cool SM
    Stem Cells; 2013 Dec; 31(12):2724-36. PubMed ID: 23939995
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of fibroblast growth factor receptor 1 endocytosis promotes axonal branching of adult sensory neurons.
    Hausott B; Rietzler A; Vallant N; Auer M; Haller I; Perkhofer S; Klimaschewski L
    Neuroscience; 2011 Aug; 188():13-22. PubMed ID: 21575685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway.
    Wang F; Ying HQ; He BS; Pan YQ; Deng QW; Sun HL; Chen J; Liu X; Wang SK
    Oncotarget; 2015 Apr; 6(10):7899-917. PubMed ID: 25760077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conditional activation of FGFR1 in the prostate epithelium induces angiogenesis with concomitant differential regulation of Ang-1 and Ang-2.
    Winter SF; Acevedo VD; Gangula RD; Freeman KW; Spencer DM; Greenberg NM
    Oncogene; 2007 Jul; 26(34):4897-907. PubMed ID: 17297442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation.
    Freeman KW; Gangula RD; Welm BE; Ozen M; Foster BA; Rosen JM; Ittmann M; Greenberg NM; Spencer DM
    Cancer Res; 2003 Oct; 63(19):6237-43. PubMed ID: 14559809
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SU6668 modulates prostate cancer progression by downregulating MTDH/AKT signaling pathway.
    Qian B; Yao Y; Liu C; Zhang J; Chen H; Li H
    Int J Oncol; 2017 May; 50(5):1601-1611. PubMed ID: 28339027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER
    Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL
    Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448
    [No Abstract]   [Full Text] [Related]  

  • 55. Type 1 fibroblast growth factor receptor in cranial neural crest cell-derived mesenchyme is required for palatogenesis.
    Wang C; Chang JY; Yang C; Huang Y; Liu J; You P; McKeehan WL; Wang F; Li X
    J Biol Chem; 2013 Jul; 288(30):22174-83. PubMed ID: 23754280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FGF-2/FGFR1 neurotrophic system expression level and its basal activation do not account for the age-dependent decline of precursor cell proliferation in the subventricular zone of rat brain.
    Frinchi M; Di Liberto V; Olivieri M; Fuxe K; Belluardo N; Mudò G
    Brain Res; 2010 Oct; 1358():39-45. PubMed ID: 20816673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human prostate cell lines from normal and tumourigenic epithelia differ in the pattern and control of choline lipid headgroups released into the medium on stimulation of protein kinase C.
    Rumsby M; Schmitt J; Sharrard M; Rodrigues G; Stower M; Maitland N
    Br J Cancer; 2011 Feb; 104(4):673-84. PubMed ID: 21266973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
    Kotani H; Ebi H; Kitai H; Nanjo S; Kita K; Huynh TG; Ooi A; Faber AC; Mino-Kenudson M; Yano S
    Oncogene; 2016 Jul; 35(27):3587-97. PubMed ID: 26549034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MALAT1 as a Regulator of the Androgen-Dependent Choline Kinase A Gene in the Metabolic Rewiring of Prostate Cancer.
    De Martino S; Iorio E; Cencioni C; Aiello A; Spallotta F; Chirico M; Pisanu ME; Grassi C; Pontecorvi A; Gaetano C; Nanni S; Farsetti A
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway.
    Trousil S; Lee P; Pinato DJ; Ellis JK; Dina R; Aboagye EO; Keun HC; Sharma R
    Cancer Res; 2014 Dec; 74(23):6867-77. PubMed ID: 25267063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.